ANTHONY LAQUIDARA: Open Payments
NPI 1992313712 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 10 payments from 7 companies in 2025. Trend: 2023 $725 · 2024 $1,084 · 2025 $1,104
Food & beverage: $1,104
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $285 |
| Otsuka America Pharmaceutical, Inc. | 2 | $231 |
| Janssen Pharmaceuticals, Inc | 1 | $140 |
| ABBVIE INC. | 1 | $125 |
| Alkermes, Inc. | 1 | $124 |
| Braeburn Inc. | 1 | $108 |
| Vanda Pharmaceuticals Inc. | 1 | $91 |
Products named: Auvelity, SPRAVATO, VRAYLAR, VIVITROL, ABILIFY MAINTENA, REXULTI, BRIXADI, FANAPT.
Industry payments across FL — which companies pay providers there.
